Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

ChemoCentryx Shares Spike 300% on Phase 3 ANCA Vasculitis Trial Results

Shares of ChemoCentryx Inc. opened greater than 330% higher today after the firm reported positive topline data from its pivotal Phase 3 ADVOCATE trial of Avacopan in treatment of ANCA-associated vasculitis. After the U.S. markets closed yesterday, ChemoCentryx Inc. ...

Biotech's Topline Breast Cancer Data Impresses

Biotech's Topline Phase 3 HER2-Positive Breast Cancer Data 'Impresses' The results and commercial potential of the therapeutic are discussed in an H.C. Wainwright & Co. report. In an Oct. 22 research note, H.C. Wainwright & Co. analyst Andrew Fein reported that t...

US Inflation Reduction Act Could Supercharge Canada’s Cobalt-Related Sectors

Written by: Jessica N. Abraham The rapidly emerging battery metals market just gained a major driver that will last for decades.That driver is the US Inflation Reduction Act (IRA), which was...

IVERIC bio Shares Double After Announcing Phase 2b AMD Topline Data

Shares of IVERIC bio opened nearly 100% higher today after reporting that it successfully met its primary endpoint in its Phase 2b age-related macular degeneration study for Zimura. Early this morning, gene therapy focused biopharmaceutical company IVERIC bio Inc. (I...

Achillion Pharma Shares Open 75% Higher After Alexion Buyout Offer

Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specifi...

Buzz on the Bullboards: Cannabis Tops Health Care

(Image via HEXO Corp.) How high can we get? This past week, it has been the question on the minds of traders, when a market roller coaster saw indexes hit record highs while company earnings saw major names soar and fall in equal measure. Tapping into the larges...

Buzz on the Bullboards: The Next Pot of Gold in 2022?

(Photo of mineralization from NFGC-21-195 approximately 285m down hole depth and Right: NFGC-21-202 approximately 146m down hole depth. Image via New Found Gold Corp.) We have waited three long years for this: St. Patrick’s Day is back, and so are al...

Buzz on the Bullboards: Are We Headed for a Major Market Correction?

(Image via Datametrex AI Limited.) Datametrex AI Ltd. ( TSX-V: DM , Forum ) announced this week that achieved the highest net income and revenue in its history. A technology-focused company with exposure to Artificial Intelligence and Machine Learning, Datametr...

Buzz on the Bullboards: Top Names in Mining, Cannabis, & Industrial Stocks

Having received UL 2723 ECOLOGO Certification for Mineral Exploration Companies last week, Critical Elements Lithium Corporation ( TSX-V: CRE , Forum ) announced this week that it had retained the services of Metso Outotec and WSP in Canada (WSP) to prepare a Pha...

A Splendid Investment Opportunity…Naturally

(Click image to play video) We’re just about smackdab in the middle of New Year’s resolution time, and millions of North Americans are committing to a healthier lifestyle or just trying to shed a few pounds. Coquitlam, BC-based...
1 2 3 4 5 6 7 8 9 10 ...